Stanley Erck
Vermögen: 527 361 $ am 30.06.2026
Vermögen: 527 361 $ am 30.06.2026
Herr Stanley C. Erck ist President, Chief Executive Officer & Director bei Novavax, Inc. und ein unabhängiger Non-Executive Director bei MaxCyte, Inc. Er ist Mitglied des Board of Directors bei Novavax, Inc., der MdBio Foundation und MaxCyte, Inc. Herr Erck war zuvor als unabhängiger Direktor bei BioCryst Pharmaceuticals, Inc. beschäftigt, als President, Chief Executive Officer & Director bei Iomai Corp., als Head-Global Regulatory Affairs Vaccines bei Baxter International, Inc., als Vice President-Corporate Development bei Integrated Genetics, Inc. und als President, Chief Executive Officer & Director bei Procept, Inc. Er erhielt seinen Bachelor-Abschluss von der University of Illinois und einen MBA von der University of Chicago Booth School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MAXCYTE, INC. 0.4% | 17.06.2026 | 428’749 ( 0.4% ) | 527 361 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MAXCYTE, INC. | Direktor/Vorstandsmitglied | 01.01.2005 |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Direktor/Vorstandsmitglied | 13.05.2009 |
| Unternehmen | Position | Ende |
|---|---|---|
| NOVAVAX, INC. | Vorstandsvorsitzender | 23.01.2023 |
| BIOCRYST PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 03.12.2018 |
| IOMAI CORPORATION | Vorstandsvorsitzender | 01.01.2008 |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Corporate Officer/Principal | - |
Procept, Inc.
Procept, Inc. Pharmaceuticals: MajorHealth Technology Develops manufactures & markets drugs | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Novavax, Inc.
Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
MaxCyte, Inc.
MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Procept, Inc.
Procept, Inc. Pharmaceuticals: MajorHealth Technology Develops manufactures & markets drugs | Health Technology |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Discovers and develops vaccines and immune system stimulants | Health Technology |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Health Technology |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen